Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
1302.14
Headquarter in Copenhagen and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Pierre Kary has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 12, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13709227

FVIIA-STF COMPLEXES EXHIBITING EXOSITE-MEDIATED SUPER ACTIVITY

IPC classification:
A61K 38/48, C12N 9/64, C07K 14/745, C07K 14/705
Applicant:
Novo Nordisk Health Care AG
Agent:
Multiple attorneys, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP16754118

IMPROVING PLANT GROWTH WITH STRESS-TOLERANT RHIZOBIA

IPC classification:
C12N 1/20, C12R 1/41, A01P 21/00, A01N 63/04, A01N 25/00, A01N 63/02
Applicant:
Novozymes Bioag A/S
Agent:
Pierre Kary, Novozymes A/S
Status:
Request for examination was made
EP16766773

STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME

IPC classification:
A01P 21/00, C09D 105/00, A01C 1/06, C12N 1/04, C12N 11/10, C12R 1/01, A01N 25/00, A01N 25/28, A01N 63/02
Agent:
Pierre Kary, Novozymes A/S
Status:
Request for examination was made
EP16770399

STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME

IPC classification:
C09D 105/00, A01P 21/00, A01N 25/14, A01N 25/00, A01N 63/04, C12R 1/80, C12N 11/10, C12N 1/04, A01C 1/06
Agent:
Pierre Kary, Novozymes A/S
Status:
Request for examination was made

Please Sign in to use this feature